Cancer remains a leading cause of mortality worldwide. The therapeutic options to treat cancer are often limited, which reduces the chance to successfully treat patients. To tackle this health problem, interventions are developed such as immunotherapies to target or influence the immune system. For example, cancer vaccines that are potentially able to initiate anti-tumour responses.
